Drug intelligence / Profile preview

sesamol

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Dietary Supplement, Research Use
01

Overview

Sesamol is a natural phenolic compound and a bioactive constituent of sesame seeds (Sesamum indicum) and sesame oil. It is best known for its potent antioxidant, anti-inflammatory, neuroprotective, and potential anti-tumor properties[1][3][5][9]. Mechanistically, sesamol scavenges diverse free radicals—such as superoxide anion, hydroxyl radical, and singlet oxygen—thereby interrupting lipid peroxidation and oxidative stress pathways[7][8]. It inhibits inflammatory cytokines (TNF-α, IL-6), inflammatory enzymes, and protein kinases, and modulates brain nerve growth factor and endocannabinoid signaling via CB1 receptors, which may partly underlie its antidepressant and neuroprotective effects[1][5]. Preclinical studies have shown sesamol ameliorates inflammation and oxidative stress in models of asthma, neurodegeneration (Alzheimer’s, Parkinson’s, Huntington’s), cancer (e.g., hepatic, colon, skin), and metabolic syndromes[3][5][7][9]. Sesamol is sometimes explored as a lead compound or research chemical; however, it is not an approved pharmaceutical drug and is primarily available as a chemical or dietary supplement ingredient.

Other names
1,3-benzodioxol-5-ol3,4-methylenedioxyphenolbenzo[d][1,3]dioxol-5-olphenol 3,4-(methylenedioxy)1,2,4-trihydroxybenzene-1,2-methylene ether5-hydroxy-1,3-benzodioxolemethylene ether of oxyquinonesesame phenolsesamolr
02

Targets

CYP46A1 (Cholesterol 24-hydroxylase)TYR (Tyrosinase)BDNF (Brain-derived neurotrophic factor)CNR1 (Cannabinoid receptor 1)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on sesamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sesamol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call